June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Major Risk Factors of Diabetic Retinopathy and their Relative Importance: a Meta-analysis Pooling Data from Individual Subjects in 13 Studies
Author Affiliations & Notes
  • Jing Xie
    Department of Ophthalmology, Centre for Eye Research, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia
  • Barbara Klein
    Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WV
  • Jonathan Shaw
    Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia
  • Miho Yasuda
    Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  • Jacqueline Dekker
    Department of Epidemiology and Biostatistics, the EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands
  • Tarun Sharma
    Shri Bhagwan Mahavir Vitreoretinal Services, Tamil Nadu, India
  • Korapat Mayurasakorn
    Department of Social Medicine, Samutsakhon General Hospital, Samutsakhon, Thailand
  • Viswanathan Mohan
    Department of Ophthalmology, Madras Diabetes Research Foundation, Chennai, India
  • Ecosse Lamoureux
    Department of Ophthalmology, Centre for Eye Research, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia
    Singapore Eye Research Institute, Singapore National Eye Centre, National University of Singapore, Singapore, Singapore
  • Tien Wong
    Department of Ophthalmology, Centre for Eye Research, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia
    Singapore Eye Research Institute, Singapore National Eye Centre, National University of Singapore, Singapore, Singapore
  • Footnotes
    Commercial Relationships Jing Xie, None; Barbara Klein, None; Jonathan Shaw, None; Miho Yasuda, None; Jacqueline Dekker, None; Tarun Sharma, None; Korapat Mayurasakorn, None; Viswanathan Mohan, None; Ecosse Lamoureux, None; Tien Wong, Allergan (C), Bayer (C), Novartis (C), Pfizer (C), GSK (F), Roche (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 1537. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jing Xie, Barbara Klein, Jonathan Shaw, Miho Yasuda, Jacqueline Dekker, Tarun Sharma, Korapat Mayurasakorn, Viswanathan Mohan, Ecosse Lamoureux, Tien Wong, Meta-Analysis for Eye Disease (META-EYE) Study Group; Major Risk Factors of Diabetic Retinopathy and their Relative Importance: a Meta-analysis Pooling Data from Individual Subjects in 13 Studies. Invest. Ophthalmol. Vis. Sci. 2013;54(15):1537.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine the major risk factors for diabetic retinopathy (DR) and their relative importance in over 7000 adults with type 2 diabetes, using participant-level data pooled from 13 population-based studies.

Methods: A systematic literature review was conducted to identify population-based studies that used retinal photographs to ascertain DR and reported risk factors associated with DR for subjects with type 2 diabetes. Investigators of identified studies were contacted and asked to provide, from subjects with type 2 diabetes mellitus, individual participant data on the presence or absence of DR and known potential risk factors (age, gender, race, smoking, systolic blood pressure, hypertension medication, diabetes treatment, duration of diabetes, HbA1c, and total cholesterol). Data from all study subjects were pooled and a meta-analysis was conducted using Stata. Commonality analysis was performed in R to partition the regression effects of the major risk factors into unique and common effects using the pooled individual patient data. Unique effect identifies how much variance is unique to a given risk factor and common effect identifies the joint effects among risk factors.

Results: Thirteen studies were identified comprising 7397 subjects aged 40+ years with type 2 diabetes mellitus. The pooled prevalence of any DR was 24.1% (95% confidence interval [CI] 23.1%-25.1%. After controlling for known risk factors, age (per year, Odds ratio [OR] 1.23, 95% CI 1.04-1.45), systolic blood pressure (per 1 mmHg increase, OR 1.01, 95% CI 1.01-1.01), duration of diabetes (per year, OR 1.07, 95% CI 1.06-1.09), HbA1c (per %, OR 1.23, 95% CI 1.04-1.45) were associated with the presence of DR. Commonality analysis identified the most important risk factor for DR as duration of diabetes, explaining 4.9% and 4.8% of unique and common variances of DR, respectively. The unique and common contribution of HbA1c to DR was 3.37% and 1.52%, respectively. Forty-six percent of the total explained variation in DR was due to joint effect among the four major risk factors.

Conclusions: While diabetes duration, glycemic and blood pressure control are associated with prevalent DR in type 2 diabetes, each factor alone explain low amounts of the variability.

Keywords: 499 diabetic retinopathy • 464 clinical (human) or epidemiologic studies: risk factor assessment  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×